Education + Advocacy = Change from the "Foundation with Hope"

Click a topic below for an index of articles:

Home

Forum

New Material

Hepatitis and Stigma

HIV/AIDS and stigma (A thru H)

HIV/AIDS and stigma (I thru Z)

Impact on Relationship

Medical Stigma

Miscellaneous Articles on the Stigma of Infectious Diseases (A thru L)

Miscellaneous Articles on the Stigma of Infectious Diseases (M thru Z)

Public Health issues and stigma (A thru L)

Public Health issues and stigma (M thru Z)

Sexual issues in relationship & stigma

Sponsors

Social Security and issues of stigma in awarding claims

Statistical reports on stigma

Stereotype perception and stigma

If you would like to submit an article to this website, email us at info@hateamongstus.net  for a review of this paper

any words all words
Results per page:

It's better to light a candle than to curse the darkness

     

New Postexposure Protocol for Occupational Exposure to Bloodborne Diseases

The OSHA report, Postexposure Evaluation and Follow-Up Requirements under OSHA's Standard for Occupational Exposure to Bloodborne Diseases, includes information from a recent study showing that zidovudine prophylaxis after percutaneous exposure to HIV can reduce the risk of seroconversion by almost 80 percent, which resulted in new recommendations from the U.S. Centers for Disease Control and Prevention. These recommendations call for postexposure prophylaxis, if indicated, within one to two hours after the exposure incident.

More information on this topic can be found at the CDC's Web site (http://www.cdc.gov), including questions and answers on "Occupational Exposure to HIV" (http://www.cdc.gov/ncidod/hip/faq.htm), and the "Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus" (), from the CDC's June 28, 1997, issue of the Morbidity and Mortality Weekly Report.

     

The ADA's Division of Scientific Affairs reports that it often receives calls from dentists who have experienced a percutaneous exposure and who are unaware of the new CDC recommendations and the efficacy of postexposure prophylaxis.


 


 

 

 

 

 

 

 

 

 

 

 

 

Email: